Sort By
-
Huihui Ye
There is no curative treatment available for..
Huihui Ye
2014 Stewart Rahr-PCF Young Investigator
Huihui Ye, MD:
Harvard Medical School: Beth Israel Deaconess Medical Center
Mentors:
Steven Balk, MD, PhD
Proposal Title:
Investigation of Molecular Mechanisms and Biomarkers of Treatment Resistance in a Randomized, Phase 2 Neoadjuvant Intense Androgen Deprivation Trial in Patients with Localized, Intermediate to High Risk Prostate Cancer
-
Kosj Yamoah
The risk of developing and dying from..
Kosj Yamoah
2014 J. Eustace Wolfington-PCF Young Investigator
Kosj Yamoah, MD, PhD:
Thomas Jefferson University
Mentors:
Adam Dicker, MD, PhD, Timothy Rebbeck, PhD
Proposal Title:
Identification and Validation of a Biomarker Signature that can Improve Predictability of Aggressive Disease in Men of African Descent with Prostate Cancer
-
Kamlesh Yadav
Understanding the biology of how prostate cancer..
Kamlesh Yadav
2014 The LeFrak Family-PCF Young Investigator
Kamlesh Yadav, PhD :
Icahn School of Medicine at Mount Sinai
Mentors:
Ash Tewari, MD
Proposal Title:
Rational Design of Effective Prostate Cancer Combination Therapies
-
Kathryn Wilson
Metastatic prostate cancer is essentially incurable and..
Kathryn Wilson
2014 Heritage Medical Research Institute-PCF Young Investigator
Kathryn Wilson, ScD:
Harvard School of Public Health
Mentors:
Lorelei Mucci, ScD, Matthew Smith, MD, PhD
Proposal Title:
Bone Metabolism and Bone Metastases in Prostate Cancer
-
Yu Wang
Castrate-resistant prostate cancer (CRPC) is an aggressive,..
Yu Wang
2014 Thomas H. Lee-PCF Young Investigator
Yu Wang, MD, PhD:
New York University Lagone Medical Center
Mentors:
Susan Logan, PhD, Michael Garabedian, PhD
Proposal Title:
Multivalent Peptidomimetic Conjugates in CRPC Treatment
-
Li Wang
The identification of biomarkers to stratify risk..
Li Wang
2014 Richard and Ellen Sandler-PCF Young Investigator
Li Wang, PhD:
Icahn School of Medicine at Mount Sinai
Mentors:
William Oh, MD and Eric Schadt, PhD
Proposal Title:
Integrative Genomics Study of Immune Signatures in Blood and Tumor Tissue for Prostate Cancer
-
Sumit Subudhi
Ipilimumab is a cancer immunotherapy that has..
Sumit Subudhi
2014 Stewart Rahr-PCF Young Investigator
Sumit Subudhi, MD, PhD:
M. D. Anderson Cancer Center
Mentors:
James Allison, PhD, Padmanee Sharma, MD, PhD
Proposal Title:
Improving Patient Selection for Immune Checkpoint Therapy: Maximizing Benefit and Minimizing Toxicities
-
Tanya Stoyanova
Few options remain for prostate cancer patients..
Tanya Stoyanova
2014 Stewart Rahr-PCF Young Investigator
Tanya Stoyanova, PhD:
University of California at Los Angeles
Mentors:
Owen Witte, MD
Proposal Title:
Proteolytically Cleaved Receptors as Oncogenes and Therapeutic Targets in Advanced Castration Resistant Prostate Cancer
-
Matthias Stephan
The immune system is a powerful natural..
Matthias Stephan
2014 Lori Milken-PCF Young Investigator
Matthias Stephan, MD, PhD:
Fred Hutchinson Cancer Research Center
Mentor:
Peter Nelson, MD
Proposal Title:
In Vivo Programming of Prostate Tumor-Specific T cells using Synthetic Nanoparticles
-
Daniel Spratt
Some prostate cancer patients who undergo radiation..
Daniel Spratt
2014 Rebecca and Nathan Milikowsky-PCF Young Investigator
Daniel Spratt, MD:
University of Michigan
Mentors:
Charles Sawyers, MD
Proposal Title:
Androgen Receptor Signaling Post-Radiotherapy: A Novel Non-Invasive Predictive Biomarker for Locally Advanced and Castrate Resistant Prostate Cancer
-
Jinjun Shi
The immune system has the power to..
Jinjun Shi
2014 J. Eustace Wolfington-PCF Young Investigator
Jinjun Shi, PhD:
Brigham and Women’s Hospital, Harvard Medical School
Mentors:
Omid Farokhzad, MD, Ulrich von Andrian, MD, PhD
Proposal Title:
mRNA-Based Immuno-Nanotherapeutics for Advanced Prostate Cancer Treatment
-
Nikolaus Schultz
Precision medicine is the generation of individualized..
Nikolaus Schultz
2014 John A. Paulson-PCF Young Investigator
Nikolaus Schultz, PhD:
Memorial Sloan-Kettering Cancer Center
Mentors:
Charles Sawyers, MD, Chris Sander, PhD
Proposal Title:
A Genomics-Guided Decision Support System for the Treatment of Prostate Cancer
-
Anirban Sahu
Long non-coding RNAs (lncRNA) are a recently..
Anirban Sahu
2014 Stewart Rahr-PCF Young Investigator
Anirban Sahu, PhD:
University of Michigan
Mentor:
Arul Chinnaiyan, MD, PhD
Proposal Title:
The Role of Long Noncoding RNA SChLAP1 in Aggressive Prostate Cancer
-
Brian Olson
The androgen receptor (AR) is the engine..
Brian Olson
2014 Stephen A. Schwarzman-PCF Young Investigator
Brian Olson, PhD:
University of Wisconsin Carbone Cancer Center
Mentors:
Douglas McNeel, MD, PhD, Glenn Liu, MD
Proposal Title:
Targeting Resistance to Androgen Deprivation Therapies using Immunotherapies Targeting the Androgen Receptor
-
David Olmos
BRCA is a gene that mediates DNA..
David Olmos
2014 Stewart Rahr-PCF Young Investigator
David Olmos, MBBS, MSc, PhD:
Spanish National Cancer Research Centre
Mentors:
Johann de Bono, MD, PhD, Manuel Hidalgo, MD, PhD
Proposal Title:
Integration of Clinical, Molecular and Biological Characteristics to Define an Aggressive Subtype of Prostate Cancer Based on Deficient Homologous Recombination
-
Todd Morgan
The androgen receptor (AR) is the engine..
Todd Morgan
2014 Stewart Rahr-PCF Young Investigator
Todd Morgan, MD:
University of Michigan
Mentors:
Arul Chinnaiyan, MD, PhD, Russell Taichman, DMD, DMSc
Proposal Title:
Defining the Role of the HGF/c-MET Axis as a Mediator of Therapeutic Resistance in Advanced Prostate Cancer
-
Rohit Malik
Therapies targeting the androgen receptor (AR) are..
Rohit Malik
2014 Stewart Rahr-PCF Young Investigator
Rohit Malik, PhD, MSc:
Research fellow, University of Michigan
Mentor:
Arul Chinnaiyan, MD, PhD
Proposal Title:
Characterization and Therapeutic Targeting of Androgen Receptor Co-activators in Castration Resistant Prostate Cancer
-
Everardo Macias
Development and progression of prostate cancer is..
Everardo Macias
2014 Stewart Rahr-PCF Young Investigator
Everardo Macias, PhD:
Duke University
Mentors:
Stephen Freedland, MD, Jen-Tsan Chi, MD, PhD
Proposal Title:
Kinase Signaling in Prostate Cancer Associated with Obesity
-
Rajan Kulkarni
Prostate cancer diagnosis and precision medicine decisions..
Rajan Kulkarni
2014 Bari Milken Bernstein and Fred Bernstein-PCF Young Investigator
Rajan Kulkarni, MD, PhD:
David Geffen School of Medicine at UCLA
Mentors:
Matthew Rettig, MD, Dino Di Carlo, PhD
Proposal Title:
Utilizing Vortex Chip for Enumeration and Determination of Single-Cell Heterogeneity of Circulating Tumor Cells in Prostate Cancer
-
Haydn Kissick
T cells are immune cells with a..
Haydn Kissick
2014 William B. Finneran-PCF Young Investigator
Haydn Kissick, PhD:
The Emory Vaccine Center and the Department of Urology, Emory University
Mentors:
Martin Sanda, MD, Rafi Ahmed, PhD
Proposal Title:
Vaccination against Patient Specific Coding Mutations to Treat Prostate Cancer
-
Charalambos Kaittanis
The poor solubility and bioavailability of many..
Charalambos Kaittanis
2014 David S. Blitzer-PCF Young Investigator
Charalambos Kaittanis, PhD:
Memorial Sloan-Kettering Cancer Center
Mentors:
Jan Grimm, MD, PhD, Steven M. Larson, MD
Proposal Title:
Overcoming Drug Resistance in Advanced Prostate Cancer with Multifunctional Nanosponges
-
Neema Jamshidi
The ability of physicians to more accurately..
Neema Jamshidi
2014 Stewart Rahr-PCF Young Investigator
Neema Jamshidi, MD, PhD:
University of California, Los Angeles
Mentors:
Michael Kuo, MD, Robert Reiter, MD
Proposal Title:
Identifying Gen-Rad-Path (Genomic-Radiology-Pathology) Correlates in Patients with Indolent versus Aggressive Prostate Cancer
-
Franklin Huang
African-American men have higher incidence and death..
Franklin Huang
2014 Stewart Rahr-PCF Young Investigator
Franklin Huang, MD, PhD:
Dana-Farber Cancer Institute
Mentors:
Levi Garraway, MD, PhD
Proposal Title:
Investigating the Genomics of African-American Prostate Cancer
-
Christopher Heaphy
Telomeres are repeating sequences of DNA located..
Christopher Heaphy
2014 Bonnie Pfeifer Evans-PCF Young Investigator
Christopher Heaphy, PhD:
Johns Hopkins University School of Medicine
Mentors:
Alan Meeker, PhD, Angelo De Marzo, PhD, Elizabeth Platz, PhD
Proposal Title:
The Telomere Biomarker for Individualized Prostate Cancer Risk Stratification and Prognostication
-
Jeremy Durack
Prostate cancer diagnosis and precision medicine treatment..
Jeremy Durack
2014 Joshua J. Harris-PCF Young Investigator
Jeremy Durack, MD, MS:
Memorial Sloan-Kettering Cancer Center
Mentor:
Howard Scher, MD
Proposal Title:
Rapid Spectroscopic Assessment of Targeted Prostate Cancer Biopsy Sufficiency at the Point-of-Care
-
Marcin Cieslik
Differentiating indolent from aggressive prostate tumors is..
Marcin Cieslik
2014 Stewart Rahr-PCF Young Investigator
Marcin Cieslik, PhD:
University of Michigan
Mentor:
Arul Chinnaiyan, MD, PhD
Proposal Title:
Clinical Implications of Expressed Pseudogene Transcripts in Metastatic Castration-Resistant Prostate Cancer
-
W. Nathaniel Brennen
T cells are a type of immune..
W. Nathaniel Brennen
2014 Clay and Lynn Hamlin-PCF Young Investigator
W. Nathaniel Brennen, PhD:
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mentors:
John Isaacs, PhD, Charles Drake, MD, PhD
Proposal Title:
T cells Engineered to Selectively Deliver a PSA-activated Protoxin to Sites of Advanced Prostate Cancer
